MILFORD, Mass., Nov. 16, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI HealthCONx 2023 Health Care Conference in Miami on Thursday, November 30th, 2023 at 8:20AM Eastern Time.
A live webcast of the event will be available on the 'Events & Presentations' section of Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.
About Waters Corporation
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
Caspar Tudor, Head of Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$328.84 |
| Daily Change: | -2.47 -0.75 |
| Daily Volume: | 330,963 |
| Market Cap: | US$19.520B |
August 14, 2024 July 31, 2024 June 03, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
